Cite
ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol
MLA
Kamini Krishnan, et al. “ELEctroconvulsive Therapy (ECT) vs. Ketamine in Patients with Treatment-Resistant Depression: The ELEKT-D Study Protocol.” Contemporary Clinical Trials, vol. 77, Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cbfd4c0f278cea1a2345791b5a6f06a&authtype=sso&custid=ns315887.
APA
Kamini Krishnan, Robert B. Ostroff, Murat Altinay, James W. Murrough, Lee C. Chang, Amit Anand, Bo Hu, Gerard Sanacora, Donald A. Malone, Samuel T. Wilkinson, Roman M. Dale, Sanjay J. Mathew, Mingyuan Shao, Charles H. Kellner, Ali Abbas Asghar-Ali, & Katherine A. Collins. (2018). ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol. Contemporary Clinical Trials, 77.
Chicago
Kamini Krishnan, Robert B. Ostroff, Murat Altinay, James W. Murrough, Lee C. Chang, Amit Anand, Bo Hu, et al. 2018. “ELEctroconvulsive Therapy (ECT) vs. Ketamine in Patients with Treatment-Resistant Depression: The ELEKT-D Study Protocol.” Contemporary Clinical Trials 77 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cbfd4c0f278cea1a2345791b5a6f06a&authtype=sso&custid=ns315887.